BetterLife Pharma net loss more than triples to CAD 2.7 million for six months ended July 31, 2026

• BetterLife Pharma reported a net loss of CAD 2.09 million for the three months ended July 31, 2026, widening from CAD 504,111.
• Loss from operations widened to CAD 1.27 million, while total expenses rose to CAD 1.27 million.
• Wages, salaries and employment expenses climbed to CAD 766,622, and consulting fees increased to CAD 147,425.
• Cash rose to CAD 973,593 as of July 31, 2026, while total liabilities increased to CAD 9.7 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BetterLife Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-005911), on September 30, 2026, and is solely responsible for the information contained therein.